AtriCure to Present at 24th Annual Roth Conference
WEST CHESTER, Ohio--(BUSINESS WIRE)--Mar 6, 2012-- AtriCure, Inc.
(Nasdaq: ATRC), a medical device company and a leader in cardiac surgical ablation systems for the treatment of atrial fibrillation and systems for the exclusion of the left atrial appendage, today announced that it will participate in the 24th Annual Roth Conference at the Ritz Carlton hotel in Laguna Niguel, California. Management is scheduled to present on Monday, March 12, 2012 at 11:30 a.m. Pacific Time.
A live audio webcast and replay of the presentation will be available for 30 days following the presentation at www.atricure.com.
About AtriCure, Inc.
AtriCure, Inc. is a medical device company and a leader in developing, manufacturing and selling innovative cardiac surgical ablation systems designed to create precise lesions, or scars, in cardiac, or heart, tissue for the treatment of atrial fibrillation, or AF, and systems for the exclusion of the left atrial appendage. For more information, please visit www.atricure.com.
CONTACT: AtriCure, Inc.
Julie A. Piton, 513-755-4561 Vice President and Chief Financial Officer email@example.com KEYWORD: UNITED STATES NORTH AMERICA CALIFORNIA OHIO INDUSTRY KEYWORD: SURGERY HEALTH CARDIOLOGY MEDICAL DEVICES OTHER HEALTH GENERAL HEALTH SOURCE: AtriCure, Inc.
Copyright Business Wire 2012 PUB: 03/06/2012 08:45 AM/DISC: 03/06/2012 08:45 AM http://www.businesswire.com/news/home/20120306005327/